Endothelial cell dysfunction: The syndrome in making

43Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Endothelial cell dysfunction is emerging as the ultimate culprit for diverse cardiovascular diseases and cardiovascular complications in patients with chronic renal diseases, yet the definition of this new syndrome, its pathophysiology and therapy remain poorly defined. Here, we summarize some molecular mechanisms leading from hyperhomocysteinemia, elevated asymmetric dimethylarginine (ADMA) and advanced glycation end products (AGEs)-modified proteins to atherogenic endothelial phenotype and offer a model of endothelial dysfunction based on the interconnectedness of diverse functions. © 2005 by the International Society of Nephrology.

Cite

CITATION STYLE

APA

O’Riordan, E., Chen, J., Brodsky, S. V., Smirnova, I., Li, H., & Goligorsky, M. S. (2005). Endothelial cell dysfunction: The syndrome in making. In Kidney International (Vol. 67, pp. 1654–1658). Blackwell Publishing Inc. https://doi.org/10.1111/j.1523-1755.2005.00256.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free